India's Natco Pharma Applies For Nation's First Compulsory License, Bayer's Nexavar
This article was originally published in PharmAsia News
Executive Summary
Natco Pharma of India has filed the nation's first request for a compulsory license to be allowed to market a generic of a drug still under patent protection, this one by Germany's Bayer